# Francis Ho

> Francis Ho is a Series B investor at Walden Catalyst (Menlo Park) backing Medical and Computer. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Walden Catalyst](https://shizune.co/investors/profile/walden-catalyst)
- Location: Menlo Park, United States
- Total investments: 3
- Last investment: Jun 2022
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/francis-ho-b47338/

Francis Ho is a Series B investor at Walden Catalyst in Menlo Park focused on Medical and Computer. Francis Ho - Managing Director @ Walden Catalyst

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Computer | 1 | 33% |
| Genetics | 1 | 33% |
| Health Care | 1 | 33% |
| Life Science | 1 | 33% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 67% |
| Series A | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| United Kingdom | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Peptone | We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets. | $40M | Series A | Jun 09, 2022 |  |
| Genome Medical | Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health andwell-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.The company was founded in 2016 and is based in South San Francisco, California, United States. | $14M | Series B | Jul 01, 2020 |  |
| IonQ | IONQ develops general-purpose quantum information processors to solve the world’s complex problems. Its unique trapped ion approach combines unmatched physical performance, perfect qubit replication, optical networkability, and highly optimized algorithms to create a quantum computer that is as scalable as it is powerful and that will support abroad array of applications across a variety of industries.It was founded in 2015 and is based in College Park, Maryland. | $55M | Series B | Oct 22, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [ACME Capital](https://shizune.co/investors/profile/acme-capital) — VC Fund, 1 deal together
- [A&E Investments](https://shizune.co/investors/profile/a-e-investment) — VC Fund, 1 deal together
- [Airbus Ventures](https://shizune.co/investors/profile/airbus-ventures) — VC Fund, 1 deal together
- [Amazon](https://shizune.co/investors/profile/amazon) — VC Fund, 1 deal together
- [Avestria Ventures](https://shizune.co/investors/profile/avestria-ventures) — VC Fund, 1 deal together
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 1 deal together

## About Walden Catalyst

VC Fund · San Francisco, United States

Walden Catalyst provides early-stage investments and operational expertise in data, deep tech, AI, cloud, and digital biology.The venture capital firm is a legacy from Walden International and Samsung Catalyst Fund. It is committed to leveraging its operational and investing experience to help early-stage entrepreneurs rapidly scale and innovateas they build the next generations of businesses. Walden Catalyst partners with the next wave of industry visionaries to help entrepreneurs unlock innovation and accelerate growth.

5 contacts available at Walden Catalyst.

| Name | Title | Profile |
| --- | --- | --- |
| Francis Ho | Managing Director | https://shizune.co/investors/profile/francis-ho-2 |
| Nicolas Autret | Partner | https://shizune.co/investors/profile/nicolas-autret |
| Dr Carina Tyrrell | Investor and Chief of Staff | https://shizune.co/investors/profile/filippo-falaschi |
| Lip-Bu Tan | Managing Partner | https://shizune.co/investors/profile/lip-bu-tan |
| Victoria Slivkoff | Head of Ecosystem | https://shizune.co/investors/profile/victoria-slivkoff |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Francis Ho invest in?

Francis Ho invests primarily in Medical, Computer and Genetics startups, most often at Series B and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Francis Ho last invest?

The most recent investment recorded for Francis Ho closed in Jun 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co